NCT07446465 2026-03-03FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal CancerFudan UniversityPhase 4 Not yet recruiting42 enrolled